Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015

Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
Kamilla Laut On Behalf Of The EuroSIDA Study Group

Abstract

Direct comparisons between countries in core HIV care parameters are often hampered by differences in data collection. Within the EuroSIDA study, we compared levels of antiretroviral treatment (ART) coverage and virological suppression (HIV RNA < 500 copies/mL) across Europe and explored temporal trends. In three cross-sectional analyses in 2004-05, 2009-10 and 2014-15, we assessed country-specific percentages of ART coverage and virological suppression among those on ART. Temporal changes were analysed using logistic regression. Overall, the percentage of people on ART increased from 2004-05 (67.8%) to 2014-15 (78.2%), as did the percentage among those on ART who were virologically suppressed (75.2% in 2004-05, 87.7% in 2014-15). However, the rate of improvement over time varied significantly between regions (p < 0.01). In 2014-15, six of 34 countries had both ART coverage and virological suppression of above 90% among those on ART. The pattern varied substantially across clinics within countries, with ART coverage ranging from 61.9% to 97.0% and virological suppression from 32.2% to 100%. Compared with Western Europe (as defined in this study), patients in other regions were less likely to be virologically suppressed in 2014-...Continue Reading

References

Jul 11, 2003·Lancet·A MocroftUNKNOWN EuroSIDA study group
Apr 11, 2008·HIV Medicine·A MocroftUNKNOWN EuroSIDA study group
Mar 4, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edward M GardnerWilliam J Burman
Apr 2, 2013·Lancet·Johan P MackenbachMartin McKee
Aug 24, 2013·PloS One·Marie HellebergNiels Obel
Oct 1, 2013·The Lancet Infectious Diseases·Bohdan NosykUNKNOWN STOP HIV/AIDS Study Group
Jun 13, 2014·HIV Medicine·N ChkhartishviliT Tsertsvadze
Nov 14, 2014·Journal of the International AIDS Society·Anastasia PokrovskayaOleg Yurin
Jul 21, 2015·The New England Journal of Medicine·UNKNOWN INSIGHT START Study GroupJames D Neaton
Oct 2, 2015·The Lancet. HIV·Lillian LourençoViviane D Lima
Nov 5, 2015·BMC Infectious Diseases·D Van BeckhovenUNKNOWN BREACH Belgian Research on AIDS and HIV Consortium
Nov 7, 2015·Current Opinion in HIV and AIDS·Noah HaberTill Bärnighausen
Dec 3, 2015·Journal of the International AIDS Society·Nicholas A MedlandChristopher K Fairley
May 6, 2016·AIDS·Kamilla G LautUNKNOWN EuroSIDA in EuroCoord
Jun 29, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Virginie SupervieUNKNOWN FHDH-ANRS CO4 study group
Jan 25, 2017·HIV Medicine·R S DrewT Noori

❮ Previous
Next ❯

Citations

Oct 28, 2019·HIV Medicine·K LautA Mocroft
Jan 11, 2020·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Lauren GreenbergUNKNOWN RESPOND Study Group

❮ Previous
Next ❯

Software Mentioned

EuroSIDA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.